[1]WU Q, MENG FP, MA XM, et al.Analysis of association between different HCV genotypes and serum interleukin-17, interleukin-6, and vitamin D in patients with HCV-related cirrhosis[J].JClin Hepatol, 2015, 31 (11) :1849-1852. (in Chinese) 吴勤, 孟繁平, 马雪梅, 等.丙型肝炎肝硬化患者HCV基因型与血清白细胞介素17、白细胞介素6及维生素D的关系[J].临床肝胆病杂志, 2015, 31 (11) :1849-1852.
|
[2]COSTANTINI S, CAPONE F, MAIO P, et al.Cancer biomarker profiling in patients with chronic hepatitis C virus, liver cirrhosis and hepatocellular carcinoma[J].Oncol Rep, 2013, 29 (6) :2163-2168.
|
[3]SUN XF, SHI ZQ, XU Q, et al.Role of the balance Th17/Treg in liver fibrosis[J/CD].Chin J Clinicians:Electronic Edition, 2012, 6 (24) :8243-8244. (in Chinese) 孙晓飞, 施志强, 徐庆, 等.Th17/Treg平衡在肝纤维化中的作用[J/CD].中华临床医师杂志:电子版, 2012, 6 (24) :8243-8244.
|
[4]CHEN Y, FANG JK, CHEN XZ, et al.Effects of the Treg/Th17cell balance and their associated cytokines in patients with hepatitis B infection[J].Exp Ther Med, 2015, 9 (2) :573-578.
|
[5]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical association.The guideline of prevention and treatment for hepatitis C:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1961-1979. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.丙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1961-1979.
|
[6]SILVA LD, ROCHA AM, ROCHA GA, et al.The presence of Helicobacter pylori in the liver depends on the Th1, Th17 and Treg cytokine profile of the patient[J].Mem Inst Oswaldo Cruz, 2011, 106 (6) :748-754.
|
[7]SU ZJ, YU XP, GUO RY, et al.Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B[J].Diagn Micr Infec Dis, 2013, 76 (4) :437-444.
|
[8]HAMMERICH L, HEYMANN F, TACKE F.Role of IL-17 and Th17 cells in liver diseases[J].Clin Dev Immunol, 2011, 2011 (1) :184-186.
|
[9]LIN ZZ, YU XP, SU ZJ, et al.Detection of the ratios of Treg/Th17and study on its correlation with liver function in peripheral blood of patients with chronic hepatitis B[J].Chin J Immunol, 2012, 28 (11) :1036-1040. (in Chinese) 林振忠, 余雪平, 苏智军, 等.慢性乙型肝炎患者外周血Treg/Th17比率的检测及其与肝功能的相关性研究[J].中国免疫学杂志, 2012, 28 (11) :1036-1040.
|
[10]LIU HE, YOU J, CHEN HY, et al.Study on the role of the balance Th17/Treg in the development of hepatitis B virus-related Liver Fibrosis[J].Chin Gen Prac, 2016, 19 (18) :2121-2125. (in Chinese) 刘怀鄂, 游晶, 陈红英, 等.辅助性T淋巴细胞17/调节性T淋巴细胞平衡在乙型肝炎病毒感染相关肝脏疾病进展中的作用研究[J].中国全科医学, 2016, 19 (18) :2121-2125.
|
[11]CHEN XY, ZHANG YH, MA LN, et al.Changes in NK cells and regulatory T cells among patients with refractory chronic hepatitis Cduring antiviral treatment[J].J Clin Hepatol, 2014, 30 (6) :508-513. (in Chinese) 陈晓云, 张永宏, 马丽娜, 等.难治性慢性丙型肝炎患者抗病毒治疗中NK细胞和Treg细胞的动态变化[J].临床肝胆病杂志, 2014, 30 (6) :508-513.
|
[12]CLAASSENL MA, de KNEGT RJ, TILANUS HW, et al.Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis[J].J Hepatol, 2010, 52 (3) :315-321.
|
[13]TSENG KC, HO YC, HSIEH YH, et al.Elevated frequency and function of regulatory T cells in patients with active chronic hepatitis C[J].J Gastroenterol, 2012, 47 (7) :823-833.
|
[14]LI ZQ, GU XY, PING Y, et al.Dynamic changes of regulatory Tcells and their inhibitory molecules during antiviral treatment in patients with chronic hepatitis C[J].Chin J Infect Dis, 2016, 34 (6) :332-336. (in Chinese) 李志勤, 顾心雨, 平玉, 等.慢性丙型肝炎患者抗病毒治疗后调节性T淋巴细胞及其表面免疫抑制分子的动态变化[J].中华传染病杂志, 2016, 34 (6) :332-336.
|
[15]YAO JH.Correlation of regulatory B cells and regulatory T cells in patients with chronic hepatitis C[J].Chin J Prim Med Pharm, 2016, 23 (2) :275-277. (in Chinese) 姚建华.慢性丙型肝炎患者调节性B细胞的表达及其与调节性T细胞的相互关系研究[J].中国基层医药, 2016, 23 (2) :275-277.
|
[16]SUN LJ, YU JW, LIU W, et al.The impact of antiviral therapy on the ratio of regulatory T cells and Th17 cells in patients with chronic hepatitis C[J].Chin Hepatol, 2012, 17 (1) :21-24. (in Chinese) 孙丽杰, 于建武, 刘伟, 等.抗病毒治疗对慢性丙型肝炎患者Treg/Th17细胞比例变化的影响[J].肝脏, 2012, 17 (1) :21-24.
|
[17]NUNOYA J, WASHBURN ML, KOVALEV GI, et al.Regulatory Tcells prevent liver fibrosis during HIV type 1 infection in a humanized mouse model[J].J Infect Dis, 2014, 209 (7) :1039-1044.
|
[18]CHANG Q, WANG YK, ZHAO Q, et al.Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C[J].J Gastroenterol Hepatol, 2012, 27 (2) :273-278.
|
[19]LOU M, YOU J, LIU HE, et al.Changes of peripheral Th17 and Treg and Th17/Treg balance in patients with chronic hepatitis B virus infection[J].Chin Gen Prac, 2016, 19 (18) :2115-2120. (in Chinese) 娄鸣, 游晶, 刘怀鄂, 等.慢性乙型肝炎病毒感染者外周血辅助性T淋巴细胞17和调节性T淋巴细胞的变化及二者平衡的研究[J].中国全科医学, 2016, 19 (18) :2115-2120.
|
[20]WANG GQ, WANG XF, WANG L, et al.Changes and significance of Th17 and Treg cells as well as their associated cytokines in peripheral blood of patients with chronic hepatitis C and cirrhosis[J].Chin J Immunol, 2016, 32 (6) :882-886. (in Chinese) 王国戗, 王小方, 汪磊, 等.Th17和Treg细胞以及其相关细胞因子在慢性丙型肝炎以及丙型肝炎肝硬化病人外周血中的变化及意义[J].中国免疫学杂志, 2016, 32 (6) :882-886.
|
[21]D'ARGENIO G, MAZZONE G, RIBECCO MT, et al.Garlic extract attenuating rat liver fibrosis by inhibiting TGF-β1[J].Clin Nutr, 2013, 32 (2) :252-258.
|
[22]GOTO K, LIN W, ZHANG L, et al.The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-βsignaling[J].J Hepatol, 2013, 59 (5) :942-948.
|
[23]HAO C, ZHOU Y, HE Y, et al.Imbalance of regulatory T cells and Thelper type 17 cells in patients with chronic hepatitis C[J].Immunology, 2014, 143 (4) :531-538.
|
[24]ZHENG S, NING Z.Therapeutic effect of CD4+CD25+regulatory Tcells and transforming growth factor beta-1 on patients with hepatocellular carcinoma[J/CD].Chin J Liver Dis:Electronic Edition, 2012, 4 (4) :9-12. (in Chinese) 郑盛, 宁珠.原发性肝癌患者CD4CD25调节性T细胞及转化生长因子β1检测[J/CD].中国肝脏病杂志:电子版, 2012, 4 (4) :9-12.
|
[25]SUN Y, HUANG R, NIU H, et al.Clinical significance of Th17-associated cytokines in patients with hepatitis C[J].J Kunming Med Univ, 2014, 35 (8) :63-66. (in Chinese) 孙鹥, 黄蓉, 牛华, 等.Th17相关细胞因子在丙型肝炎患者血清中的变化及意义[J].昆明医科大学学报, 2014, 35 (8) :63-66.
|